To participate in the ODOMZO® (sonidegib) Co-Pay Program (“Program”), you must present this card, along with a valid prescription for ODOMZO, to your pharmacist. Patients with commercial health insurance who qualify to participate may pay as little as $10 per month for ODOMZO. Enrollment is subject to the Eligibility Rules and Terms and Conditions, stated below. If you have any questions regarding Eligibility, the Terms and Conditions, or to discontinue participation, please call 1-877-ODOMZO-1 (1-877-636-6961) (8:00 AM-8:00 PM EST, Monday-Friday).

Eligibility Rules

  • To participate in this Program, you must have commercial health insurance and be a resident of the United States, Puerto Rico, Guam, or the Virgin Islands
  • Patients who are members of health plans (often termed "maximizer" plans) that claim to reduce their patients' out-of-pocket costs may have a reduced maximum program benefit of $6,000 per calendar year. Out-of-pocket costs may be co-pay, co-insurance, or deductible
  • The following patients are ineligible for this Program
    • Patients covered under Medicaid (including Medicaid patients enrolled in a Medicaid Managed Care Plan or a qualified health plan purchased through a health insurance exchange marketplace established by a state government or the federal government)
    • Patients covered by Medicare or a Medicare Part D or Medicare Advantage plan (regardless of whether a specific prescription is covered)
    • Patients covered by TRICARE, CHAMPUS, Puerto Rico Government Health Insurance Plan or any other state or federal medical or pharmaceutical benefit program or pharmaceutical assistance program
    • Patients who are members of health plans that claim to eliminate their out-of-pocket costs are not eligible for cost support. If you are a member of one of these plans, please call 1-877-264-2440
    • Patients with no insurance

Terms and Conditions

  • You agree to not to seek any reimbursement for all or any part of the co-pay assistance received through the Program. By using this card, you are certifying that you understand the Eligibility Rules and Terms and Conditions, that you have responded truthfully to questions when activating the card, and that you will disclose and report your receipt of any Program benefits to your insurer, health plan, or any third party that pays or reimburses you for the cost of medications, if required
  • This offer may be rescinded, revoked, or cancelled at any time, without further notice, and the rules may be amended at any time, without further notice

Disclosures

  • This Program is not insurance
  • The Program is void where prohibited by law, taxed, or restricted. Any benefit provided is not transferable and cannot be combined with any other program, free trial, discount, prescription savings card, or other offer. No purchase, other than for an ODOMZO prescription, is required to participate
  • Personal data that you provide to the Program may be collected, analyzed, and shared with the program sponsor for market research and other lawful purposes, but only in aggregated and de-identified form
Click here for full Prescribing Information, including Boxed Warning and Medication Guide.
For more information, please go to www.Odomzo.com.

 

ENROLL NOW
ACTIVATE CARD
REPLACE CARD


What is ODOMZO?

ODOMZO® (sonidegib) is a prescription medicine used to treat adults with a type of skin cancer, called basal cell carcinoma, that has come back following surgery or radiation or that cannot be treated with surgery or radiation.

It is not known if ODOMZO is safe and effective in children.

Important Safety Information

What is the most important information I should know about ODOMZO?

ODOMZO can cause your baby to die before it is born (be stillborn) or cause your baby to have severe birth defects.

For females who can become pregnant:

  • You should talk to your healthcare provider about the risks of ODOMZO to your unborn child.
  • Your healthcare provider will do a pregnancy test before you start taking ODOMZO.
  • In order to avoid pregnancy, you should use birth control during treatment, and for at least 20 months after your final dose of ODOMZO. Talk to your healthcare provider about what birth control method is right for you during this time.
  • Talk to your healthcare provider right away if you have unprotected sex or if you think your birth control has failed.
  • Tell your healthcare provider right away if you become pregnant or think that you may be pregnant.

For males:

  • It is not known if ODOMZO is present in semen. Do not donate semen while you are taking ODOMZO and for at least 8 months after your final dose.
  • You should always use a condom, even if you have had a vasectomy, during sex with female partners who are pregnant or who are able to become pregnant, during treatment with ODOMZO and for at least 8 months after your final dose to protect your female partner from being exposed to ODOMZO.
  • Tell your healthcare provider right away if your partner becomes pregnant or thinks she is pregnant while you are taking ODOMZO.

Exposure to ODOMZO during pregnancy:

If you think that you or your female partner may have been exposed to ODOMZO during pregnancy, talk to your healthcare provider right away. If you become pregnant during treatment with ODOMZO, you or your healthcare provider should report your pregnancy to Sun Pharmaceutical Industries, Inc. at 1-800-406-7984.

What are possible side effects of ODOMZO?

ODOMZO can cause serious side effects, including:

  • See "What is the most important information I should know about ODOMZO?"
  • Muscle Problems. Muscle spasms and muscle pain are common with ODOMZO, but can also sometimes be symptoms of serious muscle problems. ODOMZO can increase your risk of muscle pain and, rarely a serious condition caused by injury to the muscles (rhabdomyolysis) that can lead to kidney damage. Tell your healthcare provider right away if you develop any new or worsening muscle spasms, pain or tenderness, dark urine, or decreased amount of urine during treatment with ODOMZO.
Your healthcare provider should do a blood test to check for muscle problems and to check your kidney function before you start taking ODOMZO, during treatment, and if you develop muscle problems.

The most common side effects of ODOMZO include:

  • hair loss.
  • change in taste.
  • tiredness.
  • nausea.
  • diarrhea.
  • weight loss.
  • decreased appetite.
  • vomiting.
  • stomach area (abdominal) pain.
  • itching
  • headache

What should I tell my healthcare provider before taking ODOMZO?

Before you take ODOMZO, tell your healthcare provider if you:

  • have muscle pain or spasms, or have a history of a muscle disorder called rhabdomyolysis or myopathy
  • have any other medical conditions
  • are pregnant or plan to become pregnant. See "What is the most important information I should know about ODOMZO?"
  • are breastfeeding or plan to breastfeed. It is not known if ODOMZO passes into your breast milk. Do not breastfeed during treatment and for 20 months after your final dose of ODOMZO. Talk to your healthcare provider about the best way to feed your baby during this time.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. ODOMZO may affect the way other medicines work, and other medicines can affect how ODOMZO works. Taking ODOMZO with other medicines can cause serious side effects.

What should I avoid while taking ODOMZO® (sonidegib)?

Do not donate blood or blood products while you are taking ODOMZO and for 20 months after your final dose. Do not donate semen while taking ODOMZO and for at least 8 months after your final dose.

ODOMZO can cause absence of menstrual periods (amenorrhea) in females who are able to become pregnant. It is not known if amenorrhea is permanent. Talk to your healthcare provider if you have concerns about fertility.

General information about the safe and effective use of ODOMZO

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use ODOMZO for a condition for which it was not prescribed. Do not give ODOMZO to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about ODOMZO that is written for health professionals.

This is a summary of the most important safety information about ODOMZO. These are not all of the possible side effects of ODOMZO. Talk with your healthcare provider or pharmacist about side effects. If you would like more information, the FDA-approved product labeling for ODOMZO can be found at www.ODOMZO.com or call 1-800-818-4555.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.